Pfizer and Novo Nordisk are in a heated legal and bidding war over Metsera, an obesity drug developer. Novo's $10 billion bid ...
COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk trimmed its full-year profit and sales forecasts on Wednesday as sales growth ...
Revenue was down 5.9% from last year to $16.654, after increasing 10% the previous quarter. These results were better than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results